why choose us

First received: November 09, 2022

Clinical Trial: Trial Readiness and Endpoint Assessment in LGMD R1

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A

Study Type: OBSERVATIONAL


Official Title: GRASP-01-003: Trial Readiness and Endpoint Assessment in LGMD R1

Brief Summary: This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.

Read more